Directly Observed Therapy in HIV Infected Adolescent Focus Groups

Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00079729

Enrollment

Registered

2004-03-12

Start date

2004-04-30

Completion date

2004-07-31

Last updated

2012-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Treatment Experienced

Brief summary

The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy (DOT) program that will help adolescents take their anti-HIV medications correctly.

Detailed description

The rate of HIV infection among adolescents is increasing at an alarming rate. Adherence to antiretroviral therapy has been a major challenge in achieving and maintaining adequate control of the disease in this population. DOT has been shown effective in individuals with tuberculosis (TB), but DOT in HIV infected populations has not been thoroughly examined. This study will collect information from HIV infected adolescents in order to establish a DOT program that will increase successful adherence to HIV treatment and will benefit the public by preventing development of viral resistance and reducing the risk of transmission. Adolescent participants in this study will be assigned to one of three 2-hour focus group sessions, each at a different site. The participants will complete a questionnaire and will give input about designing a DOT intervention model that will be accepted by adolescents. The model will then be used in a pilot study to determine the feasibility of implementing DOT programs in the community to help HIV infected adolescents.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to 21 Years

Healthy volunteers

Inclusion criteria

* HIV infected due to high-risk behavior * Regular attendee of local adolescent HIV support group * Current use of antiretrovirals or history of antiretroviral therapy * Permission of parent or legal guardian if participant is less than the legal age of consent. Assent of the minor participant should be obtained where required.

Exclusion criteria

* Perinatal HIV infection * Visibly distraught or emotionally unstable * Pregnancy or breast-feeding

Countries

United States

Outcome results